I-Evotaz (atazanavir + cobicistat) - Ulwazi lweNtsholongwane kaGawulayo

Ukwahlula

I-Evotaz (atazanavir + cobicistat) yinyango echanekileyo yokudibanisa izidakamizwa ze-antiretroviral ezisetyenziselwa unyango lwe- HIV . Amacandelo amabini eziyobisi athengiswa ngabanye njengeReyataz (atazanavir) kunye neTybost (cobicistat) .

I-formulation form-formulate ivumela ukuba kube lula, ngokuphindaphindiweyo kwimihla ngemihla, kunye nenxalenye ye-cobicistat ngokuphumelelayo "ukukhulisa" kunye nokugcina ingxube ye-plasma ye-atazanavir emzimbeni.

I-Evotaz ivunyiwe yi-US Food and Drug Administration (FDA) ngoJanuwari 2015 kubo bonke abanezigulane ezitsha kunye nabafundi abadala abanentsholongwane kaGawulayo-1.

Ifomu

Ithebhulethi egciniweyo enefilimu, ene-300mg atazanavir kunye ne-150mg cobicistat, i-pink in color and embossed with the numbers "3641" kwelinye icala.

Isistim

Elinye ithebhulethi ithathwa imihla ngemihla ngokutya. I-Evotaz ayikwazi ukusetyenziswa yedwa kodwa kufuneka ithathwe ngokudibanisa kunye neyodwa okanye ngaphezulu kwezidakamizwa ze-antiretroviral.

Imiyalelo

Ngaphambi kokuqala, izigulane zifanele zivavanywe ukuvavanya ukuxhaswa kwazo kwe-creinine njengoko u-Evotaz inokuphazamisa umsebenzi we-kidal (kidney), ngokuqhelekileyo kwizigulane ezinezifo ezingaziwa okanye ezingafumaniyo. Xa ulawulwa yi- Viread (tenofovir ) -iziyobisi ezinokubangela ukukhubazeka kwe-renal kwezinye-kunconywa ukuba izigulane zivavanywe ngokusesikweni kwe-creinine imvume, urlucose umchamo kunye neprotein yamanzi.

Kukwacetyiswa ukuba izigulane ezinezigulane zonyango, ngokukodwa ezo zichazwe kwi- inhibitors ye-HIV , zinikezelwe ukuhlolwa kokumelana no-gene ngaphambi kokumiselwa kweVotaz.

Ukuba uvavanyo lwe-genotypic alufumaneki, i-Evotaz kufuneka igwenywe nabani na ngaphambili abachazwe kwi-inhibitors ye-HIV.

Iziphumo eziPhakathi

KwisiGaba III sesifundo sezonyango zomntu, ininzi yeziphumo zecala yeziyobisi ziye zachongwa xa usebenzisa i-Evotaz. Iziganeko eziqhelekileyo eziqhelekileyo, ezichazwe kwi-2% okanye ngaphantsi kwezigulane ezandululwayo, zi:

Iziphumo eziqhelekileyo ezichaphazelekayo zibandakanya ukukhathala, intloko, ukulala, ukuhlanza kunye nentlungu ephezulu. Iigwegwe zamatye nazo zaphawulwa kwezinye izigulane xa uEvotaz elawulwa yiViread (tenofovir), nangona amatyala ayebhekwa njengomnene kwaye awazange abe nemiphumo yokuyeka unyango.

Ukuchasana kweziyobisi

I-Evotaz ayifanele ithathwe ngamachiza alandelayo okanye izongezelelo zemfuyo:

Ulwalamano lwe-Antiretroviral Drug

Ukusetyenziswa kweTybost ngokulandela izidakamizwa ze-antiretroviral kunokubangelwa kukulahlekelwa yempembelelo yokwelapha yesilwanyana esikhoyo okanye ukwanda kweempembelelo:

Okunye ukusebenzisana okanye ukuqwalasela

Imithombo:

Bristol-Myers Squibb. "I-Evotaz (Atazanvir + cobicistat) - UKUZIPHILA KWEZIXHUMA." ENew York, eNew York; fi kelele ngoFebruwari 3, 2015.